We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events

Expo

MEDLAB Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Advertise with Us

LGC Clinical Diagnostics

MEDLAB - INFORMA

Enhancing Efficiency in Laboratory Medicine - A Focus on Quality Control Procedures.

Labmedica Webinars

DIASYS DIAGNOSTIC SYSTEMS

Download Mobile App

Trending Articles

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Medlab Middle East Looks to The Future of Laboratories

Biomarker Algorithm Enables Noninvasive Detection of Barrett’s Esophagus and Esophageal Cancer

CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening

AI Enhances Cervical Cancer Detection

Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience

New Partnership Revolutionizes Analyses of Biological Samples

Video Library

more videos

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Erba Unveils New H 7100 Advanced Hematology Analyzer

HUMAN Diagnostics Launches Next Generation Clinical Chemistry Instruments

Tianlong Presents Advanced Instruments and Cutting-Edge Reagents

Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes

DRG Unveils Innovative Traumatic Brain Injury (TBI) Test Panel

Fapon Presents Comprehensive Range of One-Stop IVD Solutions

Partner Sites

HospiMedica

New Cardiovascular Risk Score Uses Stress Test to Predict Heart Disease More Accurately

Nanotechnology-Based Drug Delivery System Could Help Dialysis and Heart Patients Avoid Repeat Surgeries

Heart Patch Offers Innovative Treatment Option for Advanced Heart Failure Patients

Groundbreaking Tool Accurately Predicts Stroke Outcome for Better Carotid Surgery Decisions

Pioneering Technology Enables Real-Time Detection of Residual Breast Cancer During Lumpectomy

Sebia Showcases HbA1c Testing Solutions for Every Size Laboratory at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022

Image: Sebia provides a solution for every size laboratory for HbA1c testing (Photo courtesy of Sebia)

Image: Sebia provides a solution for every size laboratory for HbA1c testing (Photo courtesy of Sebia)

Sebia (Lisses, France) is showcasing its wide portfolio of instruments and tests designed to address clinical needs and improve laboratory efficiency and safety at the 2022 AACC Clinical Lab Expo. From the lowest to the highest volumes, with standalone instruments to workcell configurations, Sebia will highlight various solutions for laboratories at the event.

At AACC 2022, Sebia is demonstrating the CAPILLARYS 3 TERA MC high throughput capillary electrophoresis system that allows the combination of one to three CAPILLARYS 3 TERA instruments to a Sebia loader, with a loading capacity of 528 samples in one row. This high volume workcell provides three hours autonomy on HbA1c, and hemoglobin testing, and more than two hours on proteins, processing up to 528 samples in one go. The system can be fed continuously with additional racks, and the reagent management system allows ad-hoc reagent addition at any time, without interruption. Sebia also highlighted its portfolio of tests from multiple myeloma to metabolic disorders, hemoglobinopathies and genetic diseases.

In addition, Sebia will showcase its fully automated, random access Alegria 2 ELISA platform with its comprehensive menu of antigen assays & panels utilizing a unique Monotest strip technology that allows serum, plasma, and fecal sample testing in the same run. Visitors to the company’s AACC 2022 booth can learn about Phoresis CORE, the unified software solution for labs utilizing Sebia instruments which offers traceable patient sampling from reagent to result, remote interpretation in real-time, from anywhere, and with comprehensive patient history for all of its assays. Visitors can also learn how labs can partner with the company for its Sebia Workflow Service to maximize automation, reduce errors, and improve workflow.

Related Links:
Sebia

Visit expo >

New

Gold Member

Strep Pneumoniae Rapid Test

Strep Pneumoniae (6503 – 6573)

New

Gold Member

Antipsychotic TDM Assays

Saladax Antipsychotic Assays

New

C-Terminal Telopeptide ELISA

Urine BETA CrossLaps (CTX-I) ELISA

New

PAPP-A Test

PAPP-A Mass Units AccuBind ELISA

Latest AACC 2022 News

Channels

Clinical Chemistry

view channel

Image: The LC-MS/MS assay can serve as a reference method to validate emerging biosensors for renal function monitoring (Photo courtesy of 123RF)

Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more

Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read more

Image: Rapid and non-invasive analysis of paracetamol overdose using paper arrow-mass spectrometry (Photo courtesy of Dr Simon Maher/University of Liverpool)

New Saliva Test Rapidly Identifies Paracetamol Overdose

Paracetamol is the most widely used medication worldwide, and its easy availability contributes to its frequent misuse and overdose. Overdosing on paracetamol can lead to liver toxicity, requiring hospitalization.... Read more

Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel

Image: The rapid antigen-detection test can diagnose life-threatening tick-borne spotted fever rickettsioses (Photo courtesy of 123RF)

Rapid Antigen-Based Assay Detects Tick-Borne Diseases Before Symptoms Appear

Tick-borne spotted fever rickettsioses (SFRs) continue to pose a significant threat to otherwise healthy individuals, causing severe illness and death due to the lack of a reliable and timely diagnostic... Read more

Image: Human bowel cancer cells (Photo courtesy of Annie Cavanagh/Wellcome Collection)

DNA Testing Predicts Bowel Cancer Risk in IBD Patients

In the UK, approximately 500,000 people live with inflammatory bowel disease (IBD), with Crohn's disease and ulcerative colitis being the most prevalent types. These conditions cause inflammation in the... Read more

Image: The test could identify women at risk of postpartum depression before symptoms start (Photo courtesy of 123RF)

Blood Test Could Predict Risk of Postpartum Depression

Postpartum depression (PPD), a severe form of depression that occurs after childbirth, affects 10-15% of new mothers. It leads to emotional struggles that can have long-lasting effects on both the mother and child.... Read more

Abbott’s Alere NT-proBNP assay for the Alinity i system has been granted US FDA clearance (Photo courtesy of Abbott)

Novel Assay Diagnoses Heart Failure

Over 64 million people globally are affected by heart failure, which results in approximately one million emergency department visits annually in both the US and Europe. Heart failure can be challenging... Read more

Hematology

view channel

Image: Leukocyte count represents an easily accessible, inexpensive clinical marker (Photo courtesy of 123RF)

WBC Count Could Predict Severity of COVID-19 Symptoms

The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more

Image: The high precision platelet counting technology reduces risks that can lead to errors in cancer diagnoses (Photo courtesy of Adobe Stock)

New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors

Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more

Image: The study examined the diagnostic utility of ELISA testing for heparin-induced thrombocytopenia (Photo courtesy of 123RF)

Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy

Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read more

Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)

POC Hemostasis System Could Help Prevent Maternal Deaths

Postpartum hemorrhage (PPH), which refers to severe bleeding following childbirth, is the leading cause of maternal deaths globally. Every year, about 14 million women experience PPH, and approximately... Read more

Immunology

view channel

Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

New Discovery in Blood Immune Cells Paves Way for Parkinson's Disease Diagnostic Test

Parkinson’s disease is the fastest-growing neurological disorder globally and is the second most common after Alzheimer’s disease. Parkinson’s is a neurodegenerative condition, meaning it worsens progressively,... Read more

Image: The blood test can predict who will benefit from immune checkpoint inhibitors, a type of immunotherapy (Photo courtesy of Mount Sinai)

AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Various Cancers

Immune checkpoint inhibitors, a form of immunotherapy, are a potent tool in the fight against cancer. These inhibitors target the immune system, not the cancer directly. They work by releasing the brakes... Read more

Image: A surprising class of blood cell not typically associated with immunity plays a role in shaping the durability of immunity to vaccination (Photo courtesy of 123RF)

Blood Test Can Predict How Long Vaccine Immunity Will Last

When children receive their second measles-mumps-rubella vaccine around the time they start kindergarten, they typically gain long-lasting protection against all three viruses. In contrast, the effectiveness... Read more

Microbiology

view channel

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis

Chronic obstructive pulmonary disease (COPD) is a common respiratory condition and a major chronic lung disease that significantly impacts public health and work capacity. Long-term respiratory infections... Read more

New Point of Care Tests to Help Reduce Overuse of Antibiotics

The misuse of antibiotics—such as taking them unnecessarily, for too long, or in incorrect doses—leads to antimicrobial resistance (AMR), making infections harder to treat and increasing the risks of severe... Read more

Image: TriVerity Test is the first and only molecular blood test that can both identify bacterial and viral infections (Photo courtesy of Inflammatix)

30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease

Despite significant investment in innovation and decades of research, sepsis continues to have a high mortality rate and remains the most expensive diagnosis for healthcare systems. Hospital systems bear... Read more

Pathology

view channel

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more

Image: The device has the potential for improving the early detection of various diseases (Photo courtesy of Bangor University)

Cutting-Edge Medical Device Purifies and Concentrates Urine for Rapid Cancer Diagnosis

A groundbreaking medical device designed to purify and concentrate urine has the potential to revolutionize research and diagnosis of various health issues, including cancer. Developed by Bee Robotics... Read more

Blood Test Measures Lipoprotein (a) in Molar Units for Better Cardiovascular Risk Assessment

Around one in five people worldwide have elevated levels of lipoprotein (a), or Lp(a), which increases their risk for cardiovascular diseases such as myocardial infarction and stroke. It is advised that... Read more

Image: Researcher Shloka Negi analyzes long-read sequencing data in the UC Santa Cruz Computational Genomics lab (Photo courtesy of UC Santa Cruz)

Long-Read Sequencing to Improve Diagnosis Rate of Rare Diseases

Rare genetic diseases affect one in every 10 people globally, yet around 50% of cases remain undiagnosed despite advances in genetic technology and testing. The diagnosis process can take several years,... Read more

Technology

view channel

Image: The nanomaterial passively captures and preserves DNA and cells of interest from menstrual blood for testing (Photo courtesy of CELLECT)

Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears

Cervical cancer is the fourth most common cancer in women globally, almost always caused by the human papillomavirus (HPV), which spreads through sexual contact. The Pap test (or Pap smear) is used to... Read more

Lab-On-Chip Platform to Expedite Cancer Diagnoses

Cancer was responsible for nearly 10 million deaths in 2020, accounting for almost one in every six deaths worldwide. Timely cancer diagnosis remains a major challenge, as abnormal cellular growth is often... Read more

Image: The biosensing platform incorporates two-pass laser induced graphene with commercial transistors to simultaneously test for SARS-CoV-2 and vitamin C (Photo courtesy of Heshmat “Amir” Asgharian / Penn State)

Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2

Several studies have demonstrated that vitamin C, an essential nutrient for immune function, can help manage symptoms of viral respiratory infections like SARS-CoV-2. During the COVID-19 pandemic, at-home... Read more

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel

Image: Discovery will deploy PathAI’s AISight IMS, ArtifactDetect, and TumorDetect products globally across its biospecimens business (Photo courtesy of PathAI)

New Partnership Revolutionizes Analyses of Biological Samples

PathAI (Boston, MA, USA), a leading provider of artificial intelligence (AI)-powered technology for pathology, has entered into a strategic partnership with Discovery Life Sciences (Huntsville, AL, USA),... Read more

Image: The 24th edition of Medlab Middle East will be held from 3-6 February at the Dubai World Trade Centre (Photo courtesy of Informa Markets)

Medlab Middle East Looks to The Future of Laboratories

The medical laboratory market in the Middle East and Africa (MEA) is expected to experience substantial growth, with projections indicating it could reach USD 473.84 million by 2029, growing at a strong... Read more

Image: CANDOR Bioscience GmbH has joined the worldwide Medix Biochemica Group through an acquisition (Photo courtesy of Medix Biochemica)

Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience

Medix Biochemica (Espoo, Finland), a global leader in the supply of critical raw materials for the in vitro diagnostics (IVD) industry, has acquired CANDOR Bioscience GmbH (Allgäu, Germany), a developer... Read more

Image: The game-changing immunoassay diagnostics platform delivers results from whole blood sample in 10 minutes (Photo courtesy of SpinChip)

bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics

bioMérieux (Marcy l’Étoile, France) has agreed to acquire SpinChip Diagnostics (Oslo, Norway), the developer of a game-changing immunoassay diagnostics platform. The small benchtop analyzer is well adapted... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2024
Medica ADLM 2023
Medica AACC EUROMEDLAB 2022
MEDICA

AACC ECCMID EUROMEDLAB 2021
Medica AACC 2020
AACC COV 2019
Medica

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE